A biomarker study for atezolizumab in patients with relapsed/refractory NK/T-cell lymphoma (ATTACK)

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2020
This article has no abstract
Epistemonikos ID: ed52905e7172bfbd33e9616431cd7e8b2188a445
First added on: Apr 09, 2025